evalu
immun
felin
infecti
periton
cat
cutan
viralinduc
delay
hypersensit
vet
immunol
immunopathol
delayedtyp
hypersensit
dth
like
reaction
felin
infecti
periton
fip
viru
fipv
induc
skin
nine
cat
asymptomat
previou
challengeexposur
fipv
four
nine
previous
challengeexpos
cat
neg
virusneutr
antibodi
fipv
time
intraderm
id
test
dth
two
cat
test
dth
acut
ill
clinic
fip
cutan
dth
respons
fipv
gross
skin
reaction
fipv
inject
id
observ
six
nine
asymptomat
cat
postintraderm
inocul
hour
pih
andor
reaction
consist
focal
diamet
indur
semifirm
nonerythemat
slightli
rais
nodul
microscop
dthlike
reaction
observ
biopsi
taken
fipvinocul
skin
asymptomat
cat
pih
lesion
consist
perivascular
diffus
dermal
infiltr
macrophag
lymphocyt
polymorphonuclear
leukocyt
pmn
dermal
infiltr
maxim
pih
predominantli
mix
inflammatori
cell
five
nine
cat
pmn
four
nine
cat
pih
later
predominantli
mononuclear
cell
six
nine
cat
mix
inflammatori
cell
two
nine
cat
pih
five
nine
cat
posit
dth
skin
respons
increas
surviv
time
lethal
id
challengeexposur
fipv
compar
mean
surviv
time
fipvnaiv
nonimmun
control
cat
dthneg
id
challengeexpos
four
nine
dthposit
cat
resist
id
challengeexposur
dose
fipv
fatal
control
cat
two
four
remain
dthposit
cat
surviv
third
challengeexposur
highli
lethal
dose
fipv
given
intraperiton
four
six
dthposit
cat
die
rechalleng
necropsi
lesion
noneffus
fip
suggest
cellular
immun
may
also
involv
pathogenesi
noneffus
diseas
wherea
control
cat
dthneg
cat
clinic
diseas
succumb
effus
fip
seemingli
critic
host
defens
mechan
specif
involv
resist
felin
infecti
periton
fip
known
appar
humor
immun
protect
instead
may
promot
develop
vascular
lesion
caus
fatal
immunemedi
diseas
pedersen
boyl
weiss
scott
b
c
immun
complex
fip
viru
fipv
antifipv
immunoglobulin
complement
demonstr
lesion
serum
renal
glomeruli
cat
fip
pedersen
boyl
jacobsegeel
et
al
weiss
scott
jacobsegeel
et
al
present
believ
proven
cellmedi
immun
cmi
play
decis
role
resist
fip
hypothesi
support
sever
observ
firstli
clinic
incid
fip
increas
greatli
concurr
infect
felin
leukemia
viru
felv
felv
power
suppress
cmi
cat
hardi
rojko
olsen
secondli
sever
necrosi
deplet
lymphocyt
tdepend
area
normal
hyperplast
b
cell
spleen
lymph
node
cat
induc
fip
weiss
scott
c
hayashi
et
al
thirdli
enhanc
dissemin
fipv
macrophag
sever
diseas
thymectom
vs
control
kitten
infect
fipv
hayashi
et
al
also
blastogenesi
tcell
mitogen
suppress
cat
infect
fipv
stoddart
et
al
blastogen
respons
fipv
delayedtyp
hypersensit
dth
respons
fipv
inocul
intraconjunctiv
increas
fipvrecov
cat
pedersen
floyd
final
histopatholog
lesion
noneffus
fip
similar
lesion
tuberculosi
deep
mycos
eg
histoplasmosi
coccidioidomycosi
cmi
latter
diseas
involv
immun
develop
lesion
beeson
et
al
pedersen
black
previou
report
two
cat
describ
strong
microscop
dthlike
lesion
fipv
inocul
intraderm
id
fipresist
cat
weak
dth
respons
cat
fip
evalu
dth
skin
respons
fipv
resist
diseas
group
nine
asymptomat
cat
previous
challengeexpos
virul
fipv
two
nonimmun
cat
without
previou
exposur
fipv
two
cat
induc
fip
suggest
role
cmi
fip
diseas
resist
sourc
fipv
exposur
histori
clinic
statu
viru
neutral
serum
antibodi
titer
cat
prior
id
test
dth
summar
tabl
nine
randomsourc
mix
breed
healthi
adult
cat
select
retrospect
larger
group
cat
previous
challengeexpos
intraperiton
ip
fipv
cat
felv
testneg
elisa
seroneg
felin
coronaviru
neutral
antibodi
prior
challengeexposur
fipv
cat
hous
separ
cage
scott
ritchey
anim
isol
facil
hous
care
test
cat
complianc
standard
set
forth
guid
care
use
laboratori
anim
nih
public
larger
group
fipvinocul
cat
initi
challengeexpos
acat
either
fipvnaiv
nonimmun
time
id
test
dth
cat
previous
inocul
ip
virul
fipv
week
cat
week
cat
week
cat
evalu
dth
cat
testneg
felv
elisa
felin
coronaviru
neutral
antibodi
prior
initi
fipv
challengeexposur
bclinic
condit
time
id
test
dth
abbrevi
vnafelin
coronaviru
neutral
antibodi
titer
determin
time
id
challengeexposur
pih
spf
specificpathogenfre
cat
fipvnaiv
nonimmun
time
id
challengeexposur
r
random
sourc
cat
healthi
fipvseroneg
time
initi
ip
challengeexposur
ne
previous
expos
fipv
e
challengeexpos
prior
id
challengeexposur
n
normal
asymptomat
fip
clinic
sign
experiment
fip
neg
neg
serum
dilut
nd
determin
differ
concentr
fipv
order
establish
immun
cat
without
induc
fatal
diseas
seven
cat
given
cat
lethal
dose
ldloo
fipv
ip
surviv
cat
remain
asymptomat
week
id
challengeexposur
four
cat
remain
seroneg
fipv
three
four
seroneg
cat
howev
becam
febril
week
ip
challengeexposur
one
cat
given
ldloo
fipv
surviv
cat
asymptomat
week
id
challengeexposur
one
four
cat
given
ldloo
fipv
surviv
cat
asymptomat
week
two
randomsourc
cat
kitten
adult
cat
challengeexpos
ip
ldloo
fipv
respect
develop
clinic
sign
experiment
fip
weiss
scott
week
postinocul
id
test
dth
two
healthi
specificpathogenfre
spf
kitten
fipvnaiv
nonimmun
control
obtain
commerci
breeder
liberti
laboratori
liberti
corner
nj
felv
testneg
fipv
antibodyneg
time
id
challengeexposur
strain
fipv
american
type
cultur
collect
atcc
vr
rockvil
md
use
challengeexposur
cat
includ
id
inocul
serolog
assay
viru
propag
crandel
felin
kidney
crfk
cell
pass
five
time
laboratori
cellfre
viru
concentr
ultrafiltr
minitan
tm
millipor
bedford
frozen
store
tissu
cultur
growth
medium
aliquot
consist
eagl
minimum
essenti
medium
mem
earl
salt
solut
supplement
heatinactiv
fetal
bovin
serum
antibiot
titer
fipv
crfk
cell
approxim
tissu
cultur
infect
dose
tcidso
ml
previou
titrat
inoculum
contain
approxim
ldloo
fipvml
nine
asymptomat
cat
surviv
previou
challengeexposur
fipv
inocul
id
live
cellfre
fipv
ldloo
subsequ
evalu
grossli
microscop
induc
dth
skin
reaction
week
id
challengeexposur
four
nine
cat
still
asymptomat
no
receiv
third
challengeexposur
ldloo
fipv
given
ip
cat
monitor
daili
fever
sign
clinic
diseas
cat
except
cat
die
challengeexposur
fipv
necropsi
tissu
examin
grossli
microscop
fip
lesion
two
cat
earli
sign
induc
fip
no
inocul
id
fipv
test
dth
cat
becam
moribund
euthanat
necropsi
two
spf
kitten
no
fipvnaiv
nonimmun
control
inocul
id
fipv
evalu
induc
skin
chang
medium
alon
determin
surviv
time
also
made
nonimmun
cat
primari
challengeexposur
fipv
given
id
two
control
kitten
subsequ
euthanat
necropsi
month
later
moribund
fip
surviv
time
mortal
challengeexposur
fipv
presenc
absenc
induc
fip
clinic
form
fip
produc
effus
noneffus
evalu
cat
prior
id
skin
inocul
cat
mildli
sedat
ketamin
hydrochlorid
vetalar
park
davi
given
intramuscularli
mgkg
hair
left
right
later
flank
clip
skin
scrub
disinfect
soap
betadin
purdu
frederick
rins
water
wipe
ethyl
alcohol
dilut
growth
medium
sampl
subsequ
save
viru
titrat
test
dth
perform
inject
either
ml
fipv
contain
approxim
tcidso
ml
growth
medium
medium
control
id
skin
site
left
right
flank
respect
use
tuberculin
syring
attach
needl
postintraderm
inocul
hour
pih
cat
sedat
describ
skin
inject
site
examin
visibl
reaction
measur
record
mm
diamet
skin
wipe
alcohol
duplic
biopsi
taken
fipvinocul
media
control
skin
use
either
scalpel
biopsi
punch
baker
biopsi
punch
key
pharmaceut
florida
skin
incis
close
nylon
sutur
biopsi
sampl
fix
neutral
buffer
formalin
embed
paraffin
section
stain
hematoxylin
eosin
examin
light
microscop
photomicrograph
select
section
taken
autom
camera
system
olympu
use
black
white
film
panatom
x
asa
kodak
neutral
densiti
green
contrast
filter
viru
neutral
antibodi
vna
assay
perform
serum
sampl
heatinactiv
h
use
standard
infect
inhibitiontyp
assay
felin
embryo
cell
assay
perform
essenti
describ
pedersen
black
except
tcidso
incub
dilut
serum
start
dilut
viral
cytopath
effect
cpe
score
h
serum
vna
titer
record
reciproc
highest
dilut
serum
complet
inhibit
cpe
test
well
titer
fipv
tcidso
ml
determin
endpoint
dilut
crfk
cell
use
method
reed
muench
fipvnaiv
nonimmun
control
cat
gross
reaction
fipvor
mediuminocul
skin
observ
pih
tabl
microscop
fipvinocul
skin
pih
either
normal
cat
edema
occasion
vascul
character
mild
accumul
neutrophil
deep
dermi
cat
tabl
pih
mild
infiltr
neutrophil
mix
inflammatori
cell
nd
neg
neg
aperivascular
perifollicular
diffus
dermal
infiltr
macrophag
lymphocyt
polymorphonuclear
cell
grade
sever
follow
edema
without
occasion
inflammatori
cell
edema
plu
mild
increas
inflammatori
cell
edema
plu
moder
increas
inflammatori
cell
edema
plu
mark
increas
inflammatori
cell
neg
abnorm
find
nd
determin
inject
growth
media
control
skin
result
neg
respons
cat
except
cat
show
respons
h
edema
within
dermal
interstitium
perivascularli
fig
mediuminocul
control
skin
mild
edema
occasion
inflammatori
cell
pih
reaction
observ
pih
asymptomat
cat
previou
exposur
fipv
gross
reaction
fipvinocul
skin
observ
two
nine
cat
pih
five
cat
pih
three
cat
pih
tabl
reaction
observ
virusinocul
skin
pih
mediuminocul
skin
pih
skin
reaction
consist
focal
indur
semifirm
slightli
rais
nodul
fig
erythema
pruritu
observ
pain
respons
elicit
palpat
lesion
skin
reaction
rang
size
mm
cm
diamet
maxim
pih
microscop
id
respons
pih
gener
mild
consist
edema
edema
inflammatori
cell
respons
pih
moder
respons
pih
moderatetosever
tabl
cat
develop
moder
inflammatori
reaction
consist
perivascular
infiltr
mix
inflammatori
cell
predominantli
neutrophil
pih
cat
respons
pih
rang
edema
without
occasion
inflammatori
cell
four
nine
cat
edema
mild
infiltr
mononuclear
cell
neutrophil
four
cat
perivascular
predominantli
perivenular
perifollicular
cellular
infiltr
three
cat
mediuminocul
control
skin
pih
edema
without
occasion
inflammatori
cell
nine
nine
cat
pih
mild
three
cat
moder
two
cat
cellular
infiltr
fipvinocul
skin
six
nine
cat
perivascular
andor
perifollicular
orient
inflammatori
cell
infiltr
consist
neutrophil
macrophag
lymphocyt
mononuclear
cell
neutrophil
ratio
approxim
four
cat
predominantli
neutrophil
four
cat
section
cat
contain
increas
number
eosinophil
addit
neutrophil
macrophag
lymphocyt
mediuminocul
skin
pih
edema
without
fig
gross
skin
reaction
pih
asymptomat
cat
inocul
id
fipv
lesion
cm
diamet
cat
origin
challengeexpos
ip
fipv
week
prior
skin
inocul
shown
transient
fever
last
day
seroconvert
rare
inflammatori
cell
eight
nine
cat
cat
mild
increas
inflammatori
cell
pih
fipvinocul
skin
moder
four
cat
mark
five
cat
cellular
infiltr
adjac
blood
vessel
hair
follicl
dermal
adnexa
cat
lesion
involv
blood
vessel
wall
fibrinoid
necrosi
observ
infiltr
consist
predominantli
mix
inflammatori
cell
mononuclear
cell
neutrophil
ratio
five
cat
neutrophil
two
cat
mononuclear
cell
two
cat
three
cat
increas
number
eosinophil
inject
site
mediuminocul
skin
either
reaction
edema
without
rare
inflammatori
cell
pih
fipvinocul
skin
moder
dermal
infiltr
three
cat
mark
infiltr
four
cat
cat
shown
mark
reaction
pih
show
mild
reaction
pih
cellular
infiltr
cat
associ
blood
vessel
diffus
dermal
interstitium
around
hair
follicl
adnexa
three
cat
still
mix
inflammatori
cell
respons
fig
wherea
six
cat
predominantli
mononuclear
perivascular
reaction
fig
cat
focal
area
necrosi
polymorphonuclear
leukocyt
pmn
associ
periva
fipsymptomat
cat
gross
reaction
observ
either
fipvor
mediuminocul
skin
pih
tabl
microscop
edema
without
notic
inflammatori
cell
infiltr
fipvor
mediuminocul
skin
cat
pih
rare
inflammatori
cell
within
around
blood
vessel
wall
fipvinocul
skin
fig
cat
reaction
observ
fipvinocul
skin
pih
occasion
mild
perivascular
foci
mix
inflammatori
cell
pih
lesion
observ
mediuminocul
skin
surviv
time
postmortem
find
cat
challengeexpos
one
time
lethal
dose
fipv
shown
tabl
surviv
time
id
challengeexposur
highli
lethal
dose
fipv
increas
five
nine
dth
skin
testposit
cat
compar
mean
surviv
time
nonimmun
control
cat
tabl
four
nine
dthposit
cat
resist
two
challengeexposur
lethal
amount
fipv
two
abbrevi
dth
delayedtyp
hypersensit
id
intraderm
ip
intraperiton
pid
postintraderm
inject
day
na
applic
nd
determin
cat
succumb
fip
third
highli
lethal
challengeexposur
fipv
given
ip
two
dthposit
cat
complet
resist
total
three
separ
challengeexposur
fipv
mean
surviv
time
sem
id
challengeexposur
seven
dthposit
cat
eventu
succumb
fip
receiv
total
two
challengeexposur
lethal
dose
fipv
rang
day
total
mean
surviv
time
initi
ip
challengeexposur
fipv
cat
rang
day
four
six
dthposit
cat
necropsi
perform
predominantli
lesion
noneffus
fip
one
cat
lesion
effus
noneffus
fip
mix
type
one
cat
lesion
effus
fip
two
cat
fip
dth
skin
testneg
mean
surviv
time
challengeexposur
id
rang
day
total
mean
surviv
time
initi
challengeexposur
ip
rang
day
cat
lesion
effus
fip
mean
surviv
time
challengeexposur
id
fipv
two
fipvnaiv
nonimmun
control
cat
rang
day
cat
dthneg
time
challengeexposur
lesion
effus
fip
three
four
dthposit
cat
lesion
noneffus
fip
also
increas
surviv
time
compar
mean
surviv
time
control
contrast
two
dthposit
cat
either
effusiveor
mixedtyp
fip
lesion
increas
surviv
time
classic
dth
skin
reaction
common
id
sensit
antigen
eg
bovin
serum
albumin
bovin
gamma
globulin
egg
albumin
bacil
calmett
guerin
bcg
use
speci
difficult
demonstr
cat
transient
schultz
adam
legendr
et
al
aiken
mccusker
studi
transient
gross
skin
reaction
idinject
fipv
occur
three
nine
cat
pih
reaction
persist
h
three
cat
reaction
observ
three
cat
histolog
classic
dth
ie
tuberculininduc
skin
reaction
describ
person
guinea
pig
maxim
pih
predominantli
perivascular
perivenular
mononuclear
pmn
ratio
greater
sell
stromal
edema
gener
mild
dth
reaction
speci
result
mark
chang
vascular
permeabl
green
et
al
contrast
dth
respons
idinject
antigen
mice
crowl
cat
schultz
adam
legendr
et
al
pronounc
pmn
compon
although
contact
sensit
skin
cat
topic
challeng
hapten
produc
classic
dth
respons
predominantli
mononuclear
lymphocyt
infiltr
schultz
maguir
felin
dth
skin
lesion
idinject
fipv
describ
like
lesion
describ
previous
cat
inject
id
sensit
antigen
bcg
substanti
pmn
compon
approxim
cell
infiltr
especi
acut
phase
reaction
stromal
edema
vasomotor
chang
viz
dilat
vein
also
present
possibl
histopatholog
dth
lesion
cat
relat
certain
characterist
felin
inflammatori
respons
per
se
macrophag
attract
site
immunolog
activ
lymphokin
produc
secret
specif
antigenprim
lymphocyt
green
et
al
recruit
macrophag
subsequ
releas
inflammatori
mediat
includ
leukotrien
lt
prostaglandin
pg
complement
c
compon
strongli
chemotact
pmn
mediat
vascular
permeabl
vasomotor
chang
parker
piper
potenti
felin
macrophag
activ
cmi
reaction
produc
physiolog
activ
amount
chemotact
molecul
inflammatori
mediat
inde
signific
increas
plasma
serum
found
cat
induc
fip
jacobsegeel
et
al
complex
bound
macrophag
fip
lesion
pedersen
boyl
weiss
scott
known
whether
activ
macrophag
cat
produc
rel
greater
amount
chemotact
molecul
macrophag
speci
human
guinea
pig
whether
biochem
differ
secretori
product
effector
cell
respons
irterspeci
variat
dth
lesion
gener
characterist
reaction
time
h
gross
lesion
dermal
histopatholog
observ
id
inocul
fipv
asymptomat
fipv
challengeexpos
cat
compat
felin
dth
respons
describ
id
sensit
cat
bcg
legendr
et
al
contrast
immediatetyp
atop
arthustyp
jonesmot
cutan
basophil
hypersensit
lesion
sell
kier
et
al
fipv
nonimmun
control
cat
fipv
inoculum
caus
persist
mild
neutrophil
perivascular
respons
pih
contrast
perivascular
dermal
respons
asymptomat
cat
moder
pih
mark
mononuclear
cell
pih
edema
occasion
inflammatori
cell
skin
lesion
induc
inject
medium
id
control
cat
id
inject
medium
cat
inject
ip
media
seem
like
compon
edema
probabl
poor
fluid
resorpt
follow
inject
hyperton
solut
bovin
serum
protein
appar
lack
arthustyp
antibodymedi
lesion
fipvinocul
skin
five
cat
seroposit
surpris
vascular
lesion
fip
believ
result
arthustyp
immunopatholog
pedersen
boyl
weiss
scott
c
perhap
serum
antibodi
detect
viru
neutral
cat
complementfix
cat
may
respond
dermatolog
fipv
antigen
classic
arthustyp
reaction
anoth
possibl
fip
vascul
due
primarili
cellular
rather
humor
mechan
pedersen
interestingli
four
asymptomat
seroneg
cat
promin
perivascular
dthlike
skin
respons
fipv
natur
resist
fip
believ
depend
effect
cmi
pedersen
pedersen
black
appar
cat
develop
strong
antivir
cmi
without
humor
immun
respons
resist
fatal
fip
wherea
cat
lack
cmi
develop
poor
cmi
respons
respond
humor
develop
effus
fip
noneffus
fip
probabl
intermedi
stage
immun
effus
diseas
pedersen
pedersen
black
depend
cmi
respons
cat
low
infecti
challengeexposur
dosag
fipv
either
induc
protect
immun
promot
noneffus
fip
pedersen
studi
seven
nine
asymptomat
dth
skin
testposit
cat
origin
challengeexpos
low
dosag
fipv
four
cat
given
low
dosag
remain
vnaseroneg
week
idtest
dth
three
seroneg
cat
origin
transient
fever
within
week
primari
challengeexposur
fipv
data
shown
suggest
acut
infect
without
seroconvers
perhap
low
challengeexposur
dose
stimul
cmi
preferenti
seroneg
cat
strong
dth
skin
respons
fipv
three
dthposit
cat
respond
low
fipv
dose
strong
antibodi
respons
protect
cmi
respons
undoubtedli
also
stimul
two
cat
no
surviv
two
addit
challengeexposur
highli
lethal
dose
fipv
third
cat
success
resist
addit
challengeexposur
lethal
amount
fipv
succumb
eventu
third
dose
new
signific
find
studi
appar
loss
protect
immun
time
dthposit
cat
initi
resist
lethal
challengeexposur
fipv
system
lesion
noneffus
fip
character
perivascular
granulomat
pyogranulomat
inflamm
montali
strandberg
hayashi
et
al
seemingli
dthlike
lesion
may
repres
ineffectu
cmi
respons
fipv
dissemin
perivascularli
macrophag
weiss
scott
pedersen
pedersen
black
find
support
concept
four
six
cat
induc
dth
reaction
eventu
die
necropsi
also
noneffus
fip
anoth
dthposit
cat
lesion
noneffus
effus
fip
one
dthposit
cat
die
effus
fip
neutrophil
dermal
infiltr
skin
biopsi
pih
mix
mononuclear
cell
pmn
pih
perhap
lesion
cat
reflect
mixtur
cellular
humor
immun
respons
fipv
protect
unfortun
seem
reliabl
way
predict
histolog
differ
maxim
reaction
time
lesion
score
infiltr
cell
dth
lesion
biopsi
indic
complet
immun
one
indic
partial
respons
addit
vitro
studi
tcell
function
dth
skin
testposit
neg
cat
need
evalu
specif
relationship
viralinduc
skin
lesion
tcell
immun
resist
fip
studi
two
cat
fip
select
test
lack
poor
dth
respons
fipv
cat
induc
fip
depress
lymphocyt
blastogenesi
fipv
felin
tcell
mitogen
stoddart
et
al
addit
vitro
studi
tcell
function
cat
challengeexpos
moreov
necessari
character
potenti
immunosuppress
effect
fipv
cmi
